Insights on the Heart Failure Therapeutics Global Market to 2027 – Innovations and Development in the Heart Failure Therapeutics Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Heart Failure Therapeutics Market Research Report by Treatment, Type, Stage, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Heart Failure Therapeutics Market size was estimated at USD 20.43 billion in 2021, USD 22.06 billion in 2022, and is projected … [Read more…]

Midway International Airport, Belmont Village Senior Living Join Forces to Commemorate U.S. Veterans With ‘American Heroes’ Exhibition

CHICAGO–(BUSINESS WIRE)–The Chicago Department of Aviation (CDA) unveiled a new gallery exhibit today titled “American Heroes: Portraits of Service” at Midway International Airport, located in the pedestrian walkway between the CTA Orange Line station and the terminal. Organized by the CDA in partnership with Belmont Village Senior Living and co-sponsored by Harrison Street, the specially-curated … [Read more…]

Global Cancer Gene Therapy Market Report 2022: Increasing Investment in R&D & Technological Advancements Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy, By End-Use, By Region, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The growing demand for cancer gene therapy in diagnosing diseases is expected to drive industry growth. Furthermore, increasing investment in R&D, technological advancement, well-established infrastructure, … [Read more…]

Centra and Lifepoint Rehabilitation Plan New Inpatient Rehabilitation Facility

LYNCHBURG, Va. & BRENTWOOD, Tenn.–(BUSINESS WIRE)–Centra has announced it is partnering with Lifepoint Rehabilitation, a business unit of Lifepoint Health, to joint venture a new rehabilitation facility to serve the needs of the greater Lynchburg community. Pending customary regulatory approvals, the planning and construction will begin. This project is estimated to take two years, and … [Read more…]

Transgene Announces Positive Interim Analysis Results of Phase II Trial Evaluating TG4001 + Avelumab vs Avelumab in HPV-Positive Anogenital Cancers

Based on promising progression-free survival (PFS) interim analysis, trial to continue and an optimized number of patients to be randomized in the trial Management to host webcast presentation of the interim results today, November 2, 2022 at 6 p.m. CET / 1 p.m. EST STRASBOURG, France–(BUSINESS WIRE)–#HBV–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company … [Read more…]

CPSI Announces Business Unit and Executive Leadership Changes

Healthcare Solutions Leader Shares Strategic Leadership Updates Following Notable Quarterly Performance, Supporting Organizational Transformation and Solidifying Commitment to Improved Access to Care MOBILE, Ala.–(BUSINESS WIRE)–CPSI (NASDAQ: CPSI), a healthcare solutions company, is pleased to announce executive-level changes and three new strategic business unit appointments spanning the organization, including revenue cycle management (RCM), patient engagement, and … [Read more…]

Asia Pacific DNA Sequencing Market Report 2022: Significant Technological Advancements, the Growth of Large-Scale Sequencing Initiatives and Support by Major Governments Driving Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific DNA Sequencing Market 2021-2031 by Offering, Sequencing Type, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Asia Pacific DNA sequencing market will grow by 17.4% annually with a total addressable market cap of $75,903.7 million over 2022-2031, driven by the significant … [Read more…]

Europe Branded Generics Market Report 2022: Rise in Government Initiatives for Promoting Branded Generics Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Europe Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application, Distribution Channel, Drug Class, and Formulation Type” report has been added to ResearchAndMarkets.com’s offering. The branded generics market in Europe is expected to grow from US$ 45.81 billion in 2022 to US$ 81.30 billion by 2028; … [Read more…]

USGBC and IWBI Strengthen Their Strategic Partnership to Accelerate Healthy Sustainable Buildings

Partnership to offer dual certification pathways for LEED and WELL, designed to help the global building sector lead on climate and health SAN FRANCISCO–(BUSINESS WIRE)–The U.S. Green Building Council (USGBC) and the International WELL Building Institute (IWBI) announced today an expansion of their strategic partnership to accelerate the adoption of buildings that prioritize people, communities … [Read more…]

Revitalist Releases Supplement Line to Enhance the Results of Psychedelic Medicines

  VANCOUVER, British Columbia–(BUSINESS WIRE)–#Veterans–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), releases proprietary supplement lines to extend the results of psychedelic medicine outcomes. Through a proprietary blend of vitamins, anti-inflammatories and known cognitive enhancing ingredients, Revive+ and Restore+ have been formulated to enhance psychedelic therapy. “Providing a … [Read more…]